A Study in Patients With Advanced Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: HER2-negative Breast Cancer|Advanced Breast Cancer|Hormone Receptor-positive Breast Cancer
Interventions: DRUG: Part 1|DRUG: Part 2|DRUG: Part 3
Sponsor: Sun Pharma Advanced Research Company Limited